Acupuncture for reducing pain in stable angina

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of a standardized 12-point acupuncture protocol in alleviating pain for individuals suffering from stable angina. Participants will be randomly assigned to receive either acupuncture treatments or engage in attention control activities, such as watching non-pain related talks, over a period of five weeks. The study will assess various pain metrics and health-related quality of life measures to determine the impact of acupuncture on angina symptoms and overall patient outcomes. The long-term goal is to improve symptom management for diverse populations affected by angina, particularly those facing social disadvantages.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of stable angina or chest pain syndrome for at least 1 month (pain, pressure, or discomfort in the chest or other areas of the upper body)
* Treated with medical therapy for at least 1 month
* Experiencing symptoms at least once per week
* Speak and read English
* 21 years of age minimum

Exclusion Criteria:

* Pregnancy as some acupuncture points included in the protocol are contraindicated in pregnancy
* Physical or cognitive limitations that will prevent informed consent or completion of study tasks
* Use of steroid or prescription analgesic medications
* Concomitant biofeedback, professional massage and acupuncture.

Where it's running

• UCLA School of Nursing
  Los Angeles, California, United States Recruiting

Study contacts

• Principal investigator: Holli A. DeVon, PhD — University of California, Los Angeles
• Study coordinator: Holli A. DeVon, PhD
• Email: hdevon@sonnet.ucla.edu
• Phone: 3109107283

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Advanced invasive diagnosis for post-PCI angina in patients referred for coronary angiography

  This study tests a specialized invasive approach to find the cause of angina in people who previously had PCI and are now referred for coronary angiography.

  Recruiting at 5 sites Fundacion Investigacion Interhospitalaria Cardiovascular · Leganés, Madrid and 4 other locations · NCT07638137

• Lesion-specific angina thresholds measured during invasive coronary testing

  This project tests whether different coronary narrowings cause angina at different levels of blood-flow reduction in people with stable angina who have two blockages suitable for PCI.

  Recruiting at 6 sites Imperial College London · Basildon and 6 other locations · NCT07386418

• SirPlux Duo dual-API drug-coated balloon to treat new and in‑stent coronary blockages

  This study tests the SirPlux Duo drug‑coated balloon in adults with symptomatic coronary artery disease who have either new (de novo) small vessel blockages or in‑stent restenosis to see if it is safe and works well.

  Recruiting at 3 sites Advanced NanoTherapies · Barcelona and 2 other locations · NCT07368933

• Beta-blockers to improve coronary blood flow and resistance in people with angina and no blocked coronary arteries

  This trial will see if a beta-blocker (metoprolol) helps people with angina but no obstructive coronary arteries by improving coronary blood flow and lowering small-vessel resistance compared with a placebo.

  Recruiting Phase 4 VZW Cardiovascular Research Center Aalst · Aalst, Flanders · NCT06864234

• Effects of aerobic exercise on heart function in patients with heart disease

  This study tests whether different types of aerobic exercise can improve heart function in patients with heart disease who have recently had treatment.

  Recruiting at 2 sites Instituto de Investigación Sanitaria y Biomédica de Alicante · Alicante, Alicante and 1 other locations · NCT06788275

• Artificial intelligence to find causes of angina with no blocked arteries (ANOCA)

  This project will test whether AI analysis of intracoronary ECG and Holter monitoring can help identify vasospasm or microvascular problems in people with ongoing angina but no obstructed coronary arteries.

  Recruiting UMC Utrecht · Utrecht · NCT06387693

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.